dc.contributorUniversidade de São Paulo (USP)
dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.creatorSilva, Celio L.
dc.creatorBonato, Vania LD
dc.creatorLima, Karla M.
dc.creatorCoelho-Castelo, Arlete AM
dc.creatorFaccioli, Lucia H.
dc.creatorSartori, Alexandrina
dc.creatorDe Souza, Ana O.
dc.creatorLeao, Sylvia Cardoso [UNIFESP]
dc.date.accessioned2016-01-24T12:31:20Z
dc.date.accessioned2023-09-04T19:00:54Z
dc.date.available2016-01-24T12:31:20Z
dc.date.available2023-09-04T19:00:54Z
dc.date.created2016-01-24T12:31:20Z
dc.date.issued2001-04-01
dc.identifierFems Microbiology Letters. Amsterdam: Elsevier B.V., v. 197, n. 1, p. 11-18, 2001.
dc.identifier0378-1097
dc.identifierhttp://repositorio.unifesp.br/handle/11600/26512
dc.identifier10.1111/j.1574-6968.2001.tb10575.x
dc.identifierWOS:000167980100002
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8621748
dc.description.abstractHow the immune system kills Mycobacterium tuberculosis is still a puzzle. the classical picture of killing due to phagocytosis by activated macrophages may be only partly correct. Based on recent evidence, we express here the view that cytotoxic T lymphocytes also make an important contribution and suggest that DNA vaccines might be a good way to enhance this. (C) 2001 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
dc.languageeng
dc.publisherElsevier B.V.
dc.relationFems Microbiology Letters
dc.rightshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.rightsAcesso aberto
dc.subjectcytotoxic T lymphocyte
dc.subjectmacrophage activation
dc.subjectcellular immune response
dc.subjectDNA vaccine
dc.subjectgene therapy
dc.subjectMycobacterium tuberculosis
dc.titleCytotoxic T cells and mycobacteria
dc.typeResenha


Este ítem pertenece a la siguiente institución